AI assistant
Sending…
CATALYST PHARMACEUTICALS, INC. — Director's Dealing 2024
Jun 11, 2024
31542_dirs_2024-06-11_bd06741b-07a7-4b15-ae18-6802833386ca.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CATALYST PHARMACEUTICALS, INC. (CPRX)
CIK: 0001369568
Period of Report: 2024-06-07
Reporting Person: Del Carmen Jeffrey (Chief Commercial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-06-07 | Common stock, par value $0.001 per share | S | 7541 | $16.07 | Disposed | 18427 | Direct |
Footnotes
F1: Shares were sold on the open market for personal reasons and not as a result of any disagreement with the Company.
More from CATALYST PHARMACEUTICALS, INC.
Regulatory Filings
2026
May 11
Regulatory Filings
2026
May 7
Major Shareholding Notification
2026
Mar 26
Regulatory Filings
2026
Feb 25
Annual Report
2026
Feb 25
Director's Dealing
2026
Feb 19
Regulatory Filings
2026
Jan 12
Director's Dealing
2026
Jan 6
Director's Dealing
2026
Jan 6
Director's Dealing
2025
Dec 30